iProov to provide facial biometrics for COVID-19 digital health credential through Mvine partnership
iProov has partnered with Mvine Limited to collaborate on a prototype for a biometric antibody test results sharing system, the companies announced.
Mvine is providing a secure collaboration portal and identity management technology, while iProov provides its selfie biometric identity authentication technology with Genuine Presence Assurance. The companies plan to jointly develop a project they call ‘COVID-19 test status digital passport, with privacy protection for adults and children,’ with plans to stand up a working demonstration within two months.
“The problem we are solving is enabling Government-approved antibody tests for COVID-19 to be associated with an individual, so you can show that the test has been performed without having to give away personally identifiable information,” explains Mvine Director Frank Joshi. “Mvine’s solution will allow individuals to show that they carry the antibody for COVID-19, leading to widespread acceptance and access to the result of the test, without the need for an extensive new infrastructure.”
UK Research and Innovation (UKRI) is providing funding to Mvine to develop the solution, after the company won a competitive call for rapid COVID-19 response solution development. The Phase 1 demonstrator is expected to be completed by July 31 of this year. Innovate UK is monitoring the project’s progress.
“Ensuring consumer trust, security and privacy is essential to the success of projects in this space. iProov enables all three,” says iProov CEO Andrew Bud. “iProov’s Genuine Presence Assurance secures the link between the citizen and Mvine’s antibody test status solution in this project, which we think can make an important contribution to forming the nation’s response to the COVID-19 crisis.”
iProov’s biometric technology is also being used for contactless rail travel processes through a recently-announced project with Eurostar.